Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders

计划入组 150 人 · 首次发布于 2024 年 8 月 15 日

Evaluate Harm Reduction Products As a Second Line Intervention for Adult Smokers Who Do Not Quit with NRT

计划入组 4 人 · 首次发布于 2023 年 10 月 18 日

Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma

计划入组 38 人 · 首次发布于 2024 年 8 月 20 日

ON-04

ON-044580

ON-05

ON Semiconductor

On Target Laboratories, LLC

United States

On Target Laboratories, Inc.

United States

Novel Chemotherapy-Free Regimens Show Promise in Mantle Cell Lymphoma

Recent FDA Approvals and Clinical Trial Updates in Oncology Highlighted on OncLive On Air

Avistone's ANS014004, a Novel c-Met Inhibitor, Advances in Phase I Trials for Solid Tumors